Concerto Biosciences is a startup based in the United States, most recent round Series A, 1 tracked investor.
Based in the United States, Concerto Biosciences is a startup founded in 2020. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Concerto Biosciences develops microbial 'ensembles' as therapeutic and consumer products by leveraging its kChip technology to map and predict microbial interactions, focusing initially on skin health applications like eczema treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.